Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 145
Filter
1.
Dalton Trans ; 51(2): 478-490, 2022 Jan 04.
Article in English | MEDLINE | ID: mdl-34755751

ABSTRACT

This study presents the preparation of a novel tetra-substituted phthalonitrile (1), namely, 3,6-bis(hexyloxy)-4,5-bis(4-(trifluoromethoxy)phenoxy)phthalonitrile (1) and its metal-free (2)/metal {M = Zn (3), Cu (4), Co (5), Lu(CH3COO) (6), Lu (7)} phthalocyanines. A series of various spectroscopic methods (UV-vis, FT-IR, mass, and 1H NMR spectroscopy) were performed for the characterization of the newly synthesized compounds. The potential of compounds 2, 3, and 6 as photosensitizing materials for photodynamic and sonophotodynamic therapies was evaluated by photophysical, photochemical, and sonochemical methods. The highest singlet quantum yields were obtained for the zinc phthalocyanine derivative 3 by performing photochemical and sonochemical methods. In addition, several biological activities of the new compounds 1-7 were investigated. The newly synthesized phthalocyanines exhibited excellent DPPH scavenging activity and also DNA nuclease activity. The antimicrobial activity of the new compounds was evaluated by the disc diffusion assay. Effective microbial cell viability inhibition was observed with phthalocyanine macromolecules. The photodynamic antimicrobial therapy of the phthalocyanines showed 100% bacterial inhibition when compared to the control. They also exhibited significant biofilm inhibition activity against S. aureus and P. aeruginosa. These results indicate that new phthalocyanines are promising photodynamic antimicrobial therapies for the treatment of infectious diseases.


Subject(s)
Anti-Infective Agents/pharmacology , Antioxidants/pharmacology , Isoindoles/pharmacology , Metals/pharmacology , Photosensitizing Agents/pharmacology , Anti-Infective Agents/chemistry , Antioxidants/chemistry , Bacteria/drug effects , Bacteria/growth & development , Biofilms/drug effects , Biphenyl Compounds/chemistry , Candida parapsilosis/drug effects , Candida parapsilosis/growth & development , Candida tropicalis/drug effects , Candida tropicalis/growth & development , Deoxyribonucleases/chemistry , Halogenation , Isoindoles/chemistry , Metals/chemistry , Photochemotherapy , Photosensitizing Agents/chemistry , Picrates/chemistry , Singlet Oxygen/chemistry
2.
ScientificWorldJournal ; 2021: 8856147, 2021.
Article in English | MEDLINE | ID: mdl-34594161

ABSTRACT

Candida albicans and Candida tropicalis are the leading causes of human fungal infections worldwide. There is an increase in resistance of Candida pathogens to existing antifungal drugs leading to a need to find new sources of antifungal agents. Tormentic acid has been isolated from different plants including Callistemon citrinus and has been found to possess antimicrobial properties, including antifungal activity. The study aimed to determine the effects of tormentic and extracts from C. citrinus on C. albicans and C. tropicalis and a possible mode of action. The extracts and tormentic acid were screened for antifungal activity using the broth microdilution method. The growth of both species was inhibited by the extracts, and C. albicans was more susceptible to the extract compared to C. tropicalis. The growth of C. albicans was inhibited by 80% at 100 µg/ml of both the DCM: methanol extract and the ethanol: water extract. Tormentic acid reduced the growth of C. albicans by 72% at 100 µg/ml. The effects of the extracts and tormentic acid on ergosterol content in C. albicans were determined using a UV/Vis scanning spectrophotometer. At concentrations of tormentic acid of 25 µg/ml, 50 µg/ml, 100 µg/ml, and 200 µg/ml, the content of ergosterol was decreased by 22%, 36%, 48%, and 78%, respectively. Similarly, the DCM: methanol extract at 100 µg/ml and 200 µg/ml decreased the content by 78% and 88%, respectively. A dose-dependent decrease in ergosterol content was observed in cells exposed to miconazole with a 25 µg/ml concentration causing a 100% decrease in ergosterol content. Therefore, tormentic acid inhibits the synthesis of ergosterol in C. albicans. Modifications of the structure of tormentic acid to increase its antifungal potency may be explored in further studies.


Subject(s)
Candida albicans/drug effects , Candida tropicalis/drug effects , Ergosterol/biosynthesis , Melaleuca/chemistry , Plant Extracts/pharmacology , Triterpenes/pharmacology , Antifungal Agents/pharmacology , Candida albicans/growth & development , Candida albicans/metabolism , Candida tropicalis/growth & development , Candida tropicalis/metabolism , Molecular Structure , Nuclear Magnetic Resonance, Biomolecular , Plant Leaves/chemistry , Species Specificity , Spectrophotometry, Ultraviolet
3.
Molecules ; 26(13)2021 Jun 24.
Article in English | MEDLINE | ID: mdl-34202776

ABSTRACT

The chemical composition, antioxidant activity, and antimicrobial properties of three commercially available essential oils: rosemary (REO), lavender (LEO), and mint (MEO), were determined in the current study. Our data revealed that the major components of REO, MEO, and LEO were 1,8-cineole (40.4%), menthol (40.1%), and linalool acetate (35.0%), respectively. The highest DPPH radical-scavenging activity was identified in MEO (36.85 ± 0.49%) among the investigated EOs. Regarding antimicrobial activities, we found that LEO had the strongest inhibitory efficiencies against the growth of Pseudomonas aeruginosa and Candida (C.) tropicalis, MEO against Salmonella (S.) enterica, and REO against Staphylococcus (S.) aureus. The strongest antifungal activity was displayed by mint EO, which totally inhibited the growth of Penicillium (P.) expansum and P. crustosum in all concentrations; the growth of P. citrinum was completely suppressed only by the lowest MEO concentration. The lowest minimal inhibitory concentrations (MICs) against S. enterica, S. aureus, and C. krusei were assessed for MEO. In situ analysis on the bread model showed that 125 µL/L of REO exhibited the lowest mycelial growth inhibition (MGI) of P. citrinum, and 500 µL/L of MEO caused the highest MGI of P. crustosum. Our results allow us to make conclusion that the analysed EOs have promising potential for use as innovative agents in the storage of bakery products in order to extend their shelf-life.


Subject(s)
Anti-Infective Agents/pharmacology , Bread/microbiology , Lavandula/chemistry , Mentha/chemistry , Oils, Volatile/pharmacology , Penicillium/growth & development , Rosmarinus/chemistry , Anti-Infective Agents/chemistry , Bacteria/growth & development , Candida tropicalis/growth & development , Oils, Volatile/chemistry
4.
Microbiol Res ; 250: 126806, 2021 Sep.
Article in English | MEDLINE | ID: mdl-34157481

ABSTRACT

New strategies that enable fast and accurate visualization of Candida biofilms are necessary to better study their structure and response to antifungals agents. Here, we applied whole slide imaging (WSI) to study biofilm formation of Candida species. Three relevant biofilm-forming Candida species (C. albicans ATCC 10231, C. glabrata ATCC 2001, and C. tropicalis ATCC 750) were cultivated on glass coverslips both in presence and absence of widely used antifungals. Accumulated biofilms were stained with fluorescent markers and scanned in both bright-field and fluorescence modes using a WSI digital scanner. WSI enabled clear assessment of both size and structural features of Candida biofilms. Quantitative analyses readily detected reductions in biofilm-covered surface area upon antifungal exposure. Furthermore, we show that the overall biofilm growth can be adequately assessed across both bright-field and fluorescence modes. At the single-cell level, WSI proved adequate, as morphometric parameters evaluated with WSI did not differ significantly from those obtained with scanning electron microscopy, considered as golden standard at single-cell resolution. Thus, WSI allows for reliable visualization of Candida biofilms enabling both large-scale growth assessment and morphometric characterization of single-cell features, making it an important addition to the available microscopic toolset to image and analyse fungal biofilm growth.


Subject(s)
Biofilms/growth & development , Candida/physiology , High-Throughput Screening Assays/methods , Microscopy, Electron, Scanning/methods , Optical Imaging/methods , Candida/classification , Candida/growth & development , Candida/ultrastructure , Candida albicans/growth & development , Candida albicans/ultrastructure , Candida glabrata/growth & development , Candida glabrata/ultrastructure , Candida tropicalis/growth & development , Candida tropicalis/ultrastructure
5.
Biochem J ; 478(10): 1907-1919, 2021 05 28.
Article in English | MEDLINE | ID: mdl-33955460

ABSTRACT

Antimicrobial peptides (AMPs) are conventional antibiotic alternatives due to their broad-spectrum antimicrobial activities and special mechanisms of action against pathogens. The antifungal peptide CGA-N12 was originally derived from human chromogranin A (CGA) and consists of the 65th to 76th amino acids of the CGA N-terminal region. In the present study, we found that CGA-N12 had fungicidal activity and exhibited time-dependent inhibition activity against Candida tropicalis. CGA-N12 entered the cells to exert its antagonist activity. The internalization of CGA-N12 was energy-dependent and accompanied by actin cytoskeleton-, clathrin-, sulfate proteoglycan-, endosome-, and lipid-depleting agent-mediated endocytosis. Moreover, the CGA-N12 internalization pathway was related to the peptide concentration. The effects of CGA-N12 on the cell membrane were investigated. CGA-N12 at a low concentration less than 4 × MIC100 did not destroy the cell membrane. While with increasing concentration, the damage to the cell membrane caused by CGA-N12 became more serious. At concentrations greater than 4 × MIC100, CGA-N12 destroyed the cell membrane integrity. Therefore, the membrane activity of CGA-N12 is concentration dependant.


Subject(s)
Antifungal Agents/pharmacology , Candida tropicalis/drug effects , Cell Membrane/metabolism , Chromogranin A/metabolism , Endocytosis , Pore Forming Cytotoxic Proteins/pharmacology , Biological Transport , Calcium/metabolism , Candida tropicalis/growth & development , Cell Membrane/drug effects , Humans
6.
Biotechnol Lett ; 43(6): 1195-1209, 2021 Jun.
Article in English | MEDLINE | ID: mdl-33651230

ABSTRACT

OBJECTIVES: To increase xylose concentration of the chestnut shell hemicellulosic hydrolysate with an acceptable phenolic compound level in order to enhance xylitol production by Candida tropicalis M43. RESULTS: The xylose concentration and total phenolic compound concentration of the hydrolysate were obtained as 33.68 g/L and 77.38 mg gallic acid equivalent/L, respectively by optimization of detoxification parameters and concentration level (60 °C, 115 min contact time, 5.942% (w/v) dosage of activated charcoal, 120 strokes/min shaking rate and 0.2 volume ratio). Xylitol production was achieved in the hydrolysate by using Candida tropicalis M43. The maximum xylitol concentration was 6.30 g/L and productivity, yield and percentage of substrate conversion were calculated as 0.11 g/L h, 19.13% and 97.79%, respectively. In addition, the chestnut shell hydrolysate fortified with xylose and the maximum xylitol concentration increased to 18.08 g/L in the hydrolysate-based medium containing 80 g/L xylose. CONCLUSIONS: Optimizing detoxification conditions with concentration level was found to be useful for enhancing xylitol production. In addition, fortification of the hydrolysate caused a three fold increase in maximum xylitol concentration.


Subject(s)
Candida tropicalis/growth & development , Charcoal/chemistry , Fagaceae/chemistry , Xylitol/isolation & purification , Candida tropicalis/metabolism , Culture Media/chemistry , Fermentation , Hydrolysis , Inactivation, Metabolic , Plant Extracts/chemistry , Xylitol/chemistry
7.
Curr Genet ; 67(2): 249-254, 2021 Apr.
Article in English | MEDLINE | ID: mdl-33388851

ABSTRACT

Morphological transitions in Candida species are key factors in facilitating invasion and adapting to environmental changes. N-acetylglucosamine (GlcNAc) is a monosaccharide signalling molecule that can regulate morphological transitions in Candida albicans and Candida tropicalis. Interestingly, although the uptake and metabolic pathways of GlcNAc and GlcNAc-mediated white-to-opaque cell switching are similar between the two Candida species, GlcNAc induces hyphal development in C. albicans, whereas it suppresses hyphal development in C. tropicalis. These findings indicate that the characteristics of C. albicans and C. tropicalis in response to GlcNAc are remarkably different. Here, we compare the conserved and divergent GlcNAc-mediated signalling pathways and catabolism between the two Candida species. Deletion of NGT1, a GlcNAc transportation gene, inhibited hyphal formation in C. albicans but promoted hyphal development in C. tropicalis. To further understand these opposite effects on filamentous growth in response to GlcNAc in the two Candida species, the cyclic adenosine monophosphate/protein kinase A (cAMP/PKA) signalling pathways in both C. albicans and C. tropicalis were compared. Interestingly, GlcNAc activated the cAMP/PKA signalling pathway of the two Candida species, suggesting that the hyphal development-regulated circuit is remarkably diverse between the two species. Indeed, the Ndt80-like gene REP1, which is critical for regulating GlcNAc catabolism, exhibits distinct roles in the hyphal development of C. albicans and C. tropicalis. These data suggest possible reasons for the divergent hyphal growth response in C. albicans and C. tropicalis upon GlcNAc induction.


Subject(s)
Acetylglucosamine/genetics , Fungal Proteins/genetics , Hyphae/genetics , N-Acetylglucosaminyltransferases/genetics , Acetylglucosamine/metabolism , Biological Transport/genetics , Candida albicans/genetics , Candida albicans/growth & development , Candida tropicalis/genetics , Candida tropicalis/growth & development , Gene Expression Regulation, Fungal/genetics , Hyphae/growth & development , Hyphae/metabolism , Signal Transduction/genetics
8.
J Inorg Biochem ; 216: 111331, 2021 03.
Article in English | MEDLINE | ID: mdl-33348167

ABSTRACT

Schiff bases (SB) obtained from S-methyl dithiocarbazate and aromatic aldehydes: salicylaldehyde (H2L1), o-vanillin (H2L2), pyridoxal (H2L3) and 2,6-diformyl-4-methylphenol (H3L4), and their corresponding Zn(II)-complexes (1-4), are synthesized. All compounds are characterized by elemental analyses, infrared, UV-Vis, nuclear magnetic resonance spectroscopy and mass spectrometry. The structures of H2L2 and [Zn2(L1)2(H2O)(DMF)] (1a) (DMF = dimethylformamide) are solved by single crystal X-ray diffraction. The SB coordinates the metal center through the Ophenolate, Nimine and Sthiolate atoms. The radical scavenging activity is tested using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay, with all ligand precursors showing IC50 values ~40 µM. Cytotoxicity studies with several tumor cell lines (PC-3, MCF-7 and Caco-2) as well as a non-tumoral cell line (NHDF) are reported. Interestingly, 1 has relevant and selective antiproliferative effect against Caco-2 cells (IC50 = 9.1 µM). Their antimicrobial activity is evaluated in five bacterial strains (Klebsiella pneumoniae, Acinetobacter baumannii, Listeria monocytogenes, Pseudomonas aeruginosa and Staphylococcus aureus) and two yeast strains (Candida albicans and Candida tropicalis) with some compounds showing bacteriostatic and fungicidal activity. The minimal inhibitory concentration (MIC90) of HnL against Mycobacterium tuberculosis is also reported, with H2L2 and H3L4 showing very high activity (MIC90 < 0.6 µg/mL). The ability of the compounds to bind bovine serum albumin (BSA) and DNA is evaluated for H3L4 and [Zn2(L4)(CH3COO)] (4), both showing high binding constants to BSA (ca. 106 M-1) and ability to bind DNA. Overall, the reported compounds show relevant antitumor and antimicrobial properties, our data indicating they may be promising compounds in several fields of medicinal chemistry.


Subject(s)
Anti-Infective Agents , Antineoplastic Agents , Bacteria/growth & development , Candida albicans/growth & development , Candida tropicalis/growth & development , Coordination Complexes , Neoplasms/drug therapy , Zinc , Anti-Infective Agents/chemical synthesis , Anti-Infective Agents/chemistry , Anti-Infective Agents/pharmacology , Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , Caco-2 Cells , Coordination Complexes/chemical synthesis , Coordination Complexes/chemistry , Coordination Complexes/pharmacology , Humans , MCF-7 Cells , Neoplasms/metabolism , Neoplasms/pathology , PC-3 Cells , Schiff Bases/chemical synthesis , Schiff Bases/chemistry , Schiff Bases/pharmacology , Zinc/chemistry , Zinc/pharmacology
9.
Biomed Pharmacother ; 133: 111043, 2021 Jan.
Article in English | MEDLINE | ID: mdl-33378951

ABSTRACT

Nosocomial Candida colonization causes Systemic candidiasis in human with invasive infections in immunocompromised patients. Of all Candida spp., C. albicans is dominant in morbidity of all systemic candidiasis but C. tropicalis is phenomenal in mortality, virulence aspects and resistance development against antifungal drugs. The present study investigated the synergistic anti-virulent activity of myristic acid (MA) and palmitic acid (PA) against insidious dimorphic Candida spp. (C. albicans and C. tropicalis). In vitro and qPCR results revealed the mechanisms of MA-PA combination effectively inhibiting various virulence aspects such as biofilm, hyphal formation, secreted aspartyl proteases, lipases, ergosterol biosynthesis and drug effluxes. Further, in Danio rerio (Zebrafish), the MA-PA treatment increased the survival of animals and also the treated groups showed decreased level of fungal burden compared to the infected controls, after 3rd day of post infection. Histopathology of vital organs and SEM analysis of skin revealed a drastic recovery and reduced the inflammation of both Candida spp. infections in MA-PA treated animals. In addition, MA-PA treatment reduced the haemolysin and increased the susceptibility of Candida spp. in human blood model. Hence, this study suggested the therapeutic utilization of MA-PA as synergistic combination for their anti-inflammatory potency against systemic candidiasis and candidemia.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Antifungal Agents/pharmacology , Candida albicans/drug effects , Candida tropicalis/drug effects , Candidiasis/drug therapy , Myristic Acid/pharmacology , Palmitic Acid/pharmacology , Animals , Candida albicans/growth & development , Candida albicans/pathogenicity , Candida tropicalis/growth & development , Candida tropicalis/pathogenicity , Candidiasis/microbiology , Disease Models, Animal , Drug Synergism , Drug Therapy, Combination , Humans , Microbial Viability , Virulence , Zebrafish
10.
Appl Biochem Biotechnol ; 193(1): 205-217, 2021 Jan.
Article in English | MEDLINE | ID: mdl-32844352

ABSTRACT

Corncob is an abundant agricultural residue containing high content of hemicellulose. In this paper, the hemicellulosic hydrolysate was prepared from the hydrolysis of corncob using the solid acid sulfated zirconia as a catalyst. According to response surface analysis experiments, the optimum conditions for preparing hemicellulosic hydrolysate catalyzed by sulfated zirconia were determined as follows: solid (sulfated zirconia)-solid (corncob) ratio was 0.33, solid (corncob)-liquid (water) ratio was 0.09, temperature was 153 °C, and time was 5.3 h. Under the optimized conditions, the soluble sugar concentration was 30.12 g/L with a yield of 033 g/g corncob. Subsequently, xylitol production from the resulting hemicellulosic hydrolysate was demonstrated by Candida tropicalis, and results showed that the yield of xylitol from the hemicellulosic hydrolysate could be significantly improved on a basis of decolorization and detoxification before fermentation. The maximum yield of xylitol from the hemicellulosic hydrolysate fermented by C. tropicalis was 0.76 g/g. This study provides a new attempt for xylitol production from the hemicellulosic hydrolysate.


Subject(s)
Candida tropicalis/growth & development , Polysaccharides , Xylitol/biosynthesis , Zea mays/chemistry , Zirconium/chemistry , Polysaccharides/chemistry , Polysaccharides/metabolism
11.
Med Mycol ; 59(4): 379-391, 2021 Apr 06.
Article in English | MEDLINE | ID: mdl-32712662

ABSTRACT

NDT80-like family genes are highly conserved across a large group of fungi, but the functions of each Ndt80 protein are diverse and have evolved differently among yeasts and pathogens. The unique NDT80 gene in budding yeast is required for sexual reproduction, whereas three NDT80-like genes, namely, NDT80, REP1, and RON1, found in Candida albicans exhibit distinct functions. Notably, it was suggested that REP1, rather than RON1, is required for N-acetylglucosamine (GlcNAc) catabolism. Although Candida tropicalis, a widely dispersed fungal pathogen in tropical and subtropical areas, is closely related to Candida albicans, its phenotypic, pathogenic and environmental adaptation characteristics are remarkably divergent. In this study, we focused on the Ron1 transcription factor in C. tropicalis. Protein alignment showed that C. tropicalis Ron1 (CtRon1) shares 39.7% identity with C. albicans Ron1 (CaRon1). Compared to the wild-type strain, the C. tropicalis ron1Δ strains exhibited normal growth in different carbon sources and had similar expression levels of several GlcNAc catabolic genes during GlcNAc treatment. In contrast, C. tropicalis REP1 is responsible for GlcNAc catabolism and is involved in GlcNAc catabolic gene expressions, similar to C. albicans Rep1. However, REP1 deletion strains in C. tropicalis promote hyphal development in GlcNAc with low glucose content. Interestingly, CtRON1, but not CaRON1, deletion mutants exhibited significantly impaired hyphal growth and biofilm formation. As expected, CtRON1 was required for full virulence. Together, the results of this study showed divergent functions of CtRon1 compared to CaRon1; CtRon1 plays a key role in yeast-hyphal dimorphism, biofilm formation and virulence. LAY ABSTRACT: In this study, we identified the role of RON1, an NDT80-like gene, in Candida tropicalis. Unlike the gene in Candida albicans, our studies showed that RON1 is a key regulator of hyphal formation, biofilm development and virulence but is dispensable for N-acetylglucosamine catabolism in C. tropicalis.


Subject(s)
Acetylglucosamine/metabolism , Biofilms/growth & development , Candida tropicalis/growth & development , Candida tropicalis/genetics , Hyphae/growth & development , Receptor Protein-Tyrosine Kinases/genetics , Candida tropicalis/pathogenicity , Candida tropicalis/physiology , Gene Expression Regulation, Fungal , Virulence/genetics
12.
J Appl Microbiol ; 131(2): 728-742, 2021 Aug.
Article in English | MEDLINE | ID: mdl-33103297

ABSTRACT

AIM: Tyrosol, a quorum sensing molecule in yeasts, was reported to reduce lag phase and induces hyphae formation during cell proliferation. However, evidence of any enhancing effect of tyrosol in cellular proliferation within fermentative environment is unclear. In this investigation, selected yeast cells were assessed for their ability to synthesize tyrosol followed by examining the role of the molecule during fermentation. METHODS AND RESULTS: Tyrosols were characterized in four fermentative yeasts viz., Saccharomyces cerevisiae, Wickerhamomyces anomalus, Candida glabrata and Candida tropicalis isolated from traditional fermentative cakes of northeast India. All the isolates synthesized tyrosol while C. tropicalis exhibited filamentous growth in response to tyrosols retrieved from other isolates. Purified tyrosols showed protective behaviour in C. tropicalis and S. cerevisiae under ethanol mediated oxidative stress. During fermentation, tyrosol significantly enhanced growth of W. anomalus in starch medium while C. tropicalis exhibited growth enhancement in starch and glucose sources. The chief fermentative yeast S. cerevisiae showed notable enhancement in fermentative capacity in starch medium under the influence of tyrosol con-commitment of ethanol production. CONCLUSION: The study concludes that tyrosol exerts unusual effect in cellular growth and fermentative ability of both Saccharomyces and non-Saccharomyces yeasts. SIGNIFICANCE AND IMPACT OF THE STUDY: This is the first report of expression of tyrosol by non-conventional yeasts, where the molecule was found to exert enhancing effect during fermentation, thereby augmenting the process of metabolite production during traditional fermentation.


Subject(s)
Fermentation , Phenylethyl Alcohol/analogs & derivatives , Quorum Sensing , Yeasts/metabolism , Candida/isolation & purification , Candida/metabolism , Candida glabrata/isolation & purification , Candida glabrata/metabolism , Candida tropicalis/drug effects , Candida tropicalis/growth & development , Candida tropicalis/isolation & purification , Candida tropicalis/metabolism , Ethanol/metabolism , Ethanol/toxicity , India , Phenylethyl Alcohol/metabolism , Saccharomyces/isolation & purification , Saccharomyces/metabolism , Saccharomyces cerevisiae/drug effects , Saccharomyces cerevisiae/isolation & purification , Saccharomyces cerevisiae/metabolism , Saccharomycetales/growth & development , Saccharomycetales/isolation & purification , Saccharomycetales/metabolism
13.
PLoS One ; 15(12): e0244246, 2020.
Article in English | MEDLINE | ID: mdl-33332404

ABSTRACT

We previously found that the elevated abundance of the fungus Candida tropicalis is positively correlated with the bacteria Escherichia coli and Serratia marcescens in Crohn's disease patients and the three pathogens, when co-cultured, form a robust mixed-species biofilm. The finding suggests that these three pathogens communicate and promote biofilm formation, possibly through secretion of small signaling molecules. To identify candidate signaling molecules, we carried out a metabolomic analysis of the single-species and triple-species cultures of the three pathogens. This analysis identified 15 metabolites that were highly increased in the triple-species culture. One highly induced metabolite was indole-3-acetic acid (IAA), which has been shown to induce filamentation of certain fungi. We thus tested the effect of IAA on biofilm formation of C. tropicalis and demonstrated that IAA promotes biofilm formation of C. tropicalis. Then, we carried out isotope tracing experiments using 13C-labeled-tryptophan as a precursor to uncover the biosynthesis pathway of IAA in C. tropicalis. The results indicated that C. tropicalis synthesizes IAA through the indole-3-pyruvate pathway. Further studies using inhibitors of the indole-3-pyruvate pathway are warranted to decipher the mechanisms by which IAA influences biofilm formation.


Subject(s)
Biofilms/growth & development , Candida tropicalis/growth & development , Candidiasis/microbiology , Indoleacetic Acids/pharmacology , Indoles/metabolism , Biofilms/drug effects , Candida tropicalis/drug effects , Candida tropicalis/metabolism , Humans , Plant Growth Regulators/pharmacology , Signal Transduction
14.
Molecules ; 25(21)2020 Nov 03.
Article in English | MEDLINE | ID: mdl-33153228

ABSTRACT

(1) Background: Few antifungal drugs are currently available, and drug-resistant strains have rapidly emerged. Thus, the aim of this study is to evaluate the effectiveness of the antifungal activity from a combinational treatment of chitosan with a clinical antifungal drug on Candida albicans and Candida tropicalis. (2) Methods: Minimum inhibitory concentration (MIC) tests, checkerboard assays, and disc assays were employed to determine the inhibitory effect of chitosan with or without other antifungal drugs on C. albicans and C. tropicalis. (3) Results: Treatment with chitosan in combination with fluconazole showed a great synergistic fungicidal effect against C. albicans and C. tropicalis, but an indifferent effect on antifungal activity when challenged with chitosan-amphotericin B or chitosan-caspofungin simultaneously. Furthermore, the combination of chitosan and fluconazole was effective against drug-resistant strains. (4) Conclusions: These findings provide strong evidence that chitosan in combination with fluconazole is a promising therapy against two Candida species and its drug-resistant strains.


Subject(s)
Amphotericin B/pharmacology , Antifungal Agents/pharmacology , Candida albicans/growth & development , Candida tropicalis/growth & development , Chitosan/pharmacology , Drug Resistance, Fungal/drug effects , Fluconazole/pharmacology
15.
Toxins (Basel) ; 12(9)2020 08 20.
Article in English | MEDLINE | ID: mdl-32825220

ABSTRACT

The growing number of oral infections caused by the Candida species are becoming harder to treat as the commonly used antibiotics become less effective. This drawback has led to the search for alternative strategies of treatment, which include the use of antifungal molecules derived from natural products. Herein, crotoxin (CTX), the main toxin of Crotalus durissus terrificus venom, was challenged against Candida tropicalis (CBS94) and Candida dubliniensis (CBS7987) strains by in vitro antimicrobial susceptibility tests. Minimum inhibitory concentration (MIC), minimum fungicidal concentration (MFC), and inhibition of biofilm formation were evaluated after CTX treatment. In addition, CTX-induced cytotoxicity in HaCaT cells was assessed by MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) colorimetric assay. Native CTX showed a higher antimicrobial activity (MIC = 47 µg/mL) when compared to CTX-containing mouthwash (MIC = 750 µg/mL) and nystatin (MIC = 375 µg/mL). Candida spp biofilm formation was more sensitive to both CTX and CTX-containing mouthwash (IC100 = 12 µg/mL) when compared to nystatin (IC100 > 47 µg/mL). Moreover, significant membrane permeabilization at concentrations of 1.5 and 47 µg/mL was observed. Native CTX was less cytotoxic to HaCaT cells than CTX-containing mouthwash or nystatin between 24 and 48 h. These preliminary findings highlight the potential use of CTX in the treatment of oral candidiasis caused by resistant strains.


Subject(s)
Anti-Infective Agents, Local/pharmacology , Biofilms/drug effects , Candida tropicalis/drug effects , Candida/drug effects , Crotoxin/pharmacology , Mouthwashes/pharmacology , Anti-Infective Agents, Local/chemistry , Anti-Infective Agents, Local/isolation & purification , Biofilms/growth & development , Candida/growth & development , Candida tropicalis/growth & development , Cell Line, Transformed , Cell Membrane/drug effects , Cell Membrane/physiology , Cell Survival/drug effects , Cell Survival/physiology , Crotoxin/chemistry , Crotoxin/isolation & purification , Dose-Response Relationship, Drug , Drug Evaluation, Preclinical/methods , Humans , Male , Middle Aged , Mouthwashes/chemistry , Treatment Outcome
16.
Med Mycol ; 58(7): 887-895, 2020 Oct 01.
Article in English | MEDLINE | ID: mdl-32022851

ABSTRACT

The capacity of Candida spp. to form biofilms allows them to attach either to living or inert surfaces, promoting their persistence in hospital environments. In a previous study, we reported strain-to-strain variations in Candida spp. biofilm development, suggesting that some genotypes may be greater biofilm formers than others. In this study, we hypothesize that isolates pertaining to clusters may be found more frequently in the environment due to their ability to form biofilms compared to singleton genotypes. Two hundred and thirty-nine Candida spp. isolates (78 clusters) from candidemia patients admitted to 16 hospitals located in different cities and countries-and the same number of singleton genotypes used as controls-were tested in terms of biofilm formation using the crystal violet and the XTT reduction assays. Candida albicans clusters showed higher biofilm formation in comparison to singleton genotypes (P < .01). The biofilms formed by intra-hospital C. albicans clusters showed higher metabolic activity (P < .05). Furthermore, marked variability was found among species and type of cluster. We observed that the higher the number of isolates, the higher the variability of biofilm production by isolates within the cluster, suggesting that the production of biofilm by isolates of the same genotype is quite diverse and does not depend on the type of cluster studied. In conclusion, candidemia Candida spp. clusters-particularly in the case of C. albicans-show significantly more biomass production and metabolic activity than singleton genotypes.


Subject(s)
Biofilms/growth & development , Candida albicans/growth & development , Candida albicans/genetics , Candida parapsilosis/growth & development , Candida parapsilosis/genetics , Candida tropicalis/growth & development , Candida tropicalis/genetics , Brazil , Denmark , Genetic Variation , Genotype , Humans , Italy , Spain
17.
Appl Microbiol Biotechnol ; 104(7): 3133-3144, 2020 Apr.
Article in English | MEDLINE | ID: mdl-32076780

ABSTRACT

Six local isolates of yeasts were screened for cell mass and lipid production in mixed glucose and xylose medium. Candida tropicalis SY005 and Trichosporon (Apiotrichum) loubieri SY006 showed significant lipid accumulation of 24.6% and 32% (dry cell weight), respectively when grown in medium containing equal mass of both the sugars. SY005 produced relatively higher cell mass of 9.66 gL-1 due to higher rate of sugar consumption, which raised the lipid productivity of the organism to 0.792 gL-1day-1 as compared to 0.446 gL-1day-1 in SY006. When grown with each sugar separately, the xylose consumption rate of SY005 was found to be 0.55 gL-1 h-1 after 4 days as compared to 0.52 gL-1 h-1 for SY006. Transcript expression of the high affinity xylose transporter (Cthaxt), xylose reductase (Ctxyl1), and xylitol dehydrogenase (Ctxyl2) of SY005 was monitored to unravel such high rate of sugar consumption. Expression of all the three genes was observed to vary in mixed sugars with Cthaxt exhibiting the highest expression in presence of only xylose. Expression levels of both Ctxyl1 and Ctxyl2, involved in xylose catabolism, were maximum during 24-48 h of growth, indicating that xylose utilization started in the presence of glucose, which was depleted in the medium after 96 h. Together, the present study documents that C. tropicalis SY005 consumes xylose concomitant to glucose during early period of growth, and it is a promising yeast strain for viable production of storage lipid or other high-value oleochemicals utilizing lignocellulose hydrolysate.


Subject(s)
Candida tropicalis/metabolism , Lipids/biosynthesis , Xylose/metabolism , Candida tropicalis/genetics , Candida tropicalis/growth & development , Culture Media/chemistry , Fermentation , Fungal Proteins/genetics , Fungal Proteins/metabolism , Gene Expression Regulation, Fungal , Glucose/analysis , Glucose/metabolism , Species Specificity , Trichosporon/genetics , Trichosporon/growth & development , Trichosporon/metabolism , Xylose/analysis , Yeasts/classification , Yeasts/genetics , Yeasts/growth & development , Yeasts/metabolism
18.
Dis Mon ; 66(7): 100920, 2020 Jul.
Article in English | MEDLINE | ID: mdl-31796204

ABSTRACT

BACKGROUND: Leprosy represents a chronic progressive debilitating disease. The severe morbidity associated with leprosy predisposes the patients to opportunistic infections. To assess the oral candida prevalence and species specificity in lepromatous leprosy patients. METHODS: The cross-sectional study included 70 lepromatous leprosy patients under a multi-drug regimen for less than 1 year (group 1) and 70 healthy volunteers (group 2). Both group 1 and 2 were matched for potential confounding factors including age, gender, ethnicity, absence of HIV co-infection. Oral swab samples obtained from both groups were subjected to a series of conventional and molecular diagnostic modalities. RESULTS: Yeast growth was statistically higher (0.0006) in group 1 (45.7%) than in group 2 (18.5%). 28 of the 32 yeast growth in group 1 and all 13 yeast growth in group 2 were identified as candida. Among the 28 candida species in group 1, 23 (71.88%) were Candida albicans, 3 (9.37%) were Candida parapsilosis, 1 (3.13%) was Candida lusitaniae and 1 (3.13%) was Candida nivariensis. Among group 2, 11 (84.6%) were Candida albicans, 1 (7.7%) was Candida parapsilosis and 1 was Candida tropicalis. CONCLUSION: Oral candida prevalence is higher in leprosy patients than in healthy individuals, indicating a predisposition towards opportunistic infections. The increasing prevalence of the non-candida albicans species in leprosy is a major concern as they have shown to possess inherent resistant towards common anti-fungal agents.


Subject(s)
Candida/growth & development , Candidiasis, Oral/epidemiology , Leprosy/drug therapy , Opportunistic Infections/epidemiology , Adult , Candida/genetics , Candida/ultrastructure , Candida albicans/genetics , Candida albicans/growth & development , Candida albicans/ultrastructure , Candida parapsilosis/genetics , Candida parapsilosis/growth & development , Candida parapsilosis/ultrastructure , Candida tropicalis/genetics , Candida tropicalis/growth & development , Candida tropicalis/ultrastructure , Case-Control Studies , Cross-Sectional Studies , Female , Humans , India/epidemiology , Leprosy/complications , Leprosy/microbiology , Leprosy/pathology , Male , Middle Aged , Prevalence , Species Specificity
19.
Drug Dev Res ; 80(8): 1098-1109, 2019 12.
Article in English | MEDLINE | ID: mdl-31441101

ABSTRACT

A series of aminobenzoquinones, denoted as PQ analogs (PQ1-13), were synthesized by employing a green methodology approach using water as solvent developed by Tandon et al. Subsequently, in vitro antimicrobial potential of all PQ analogs was evaluated in a panel of seven bacterial strains (three gram positive and four gram negative bacteria) and three fungi. The antifungal profile of all PQ analogs indicated that four analogs (while PQ2, PQ9, and PQ10 were effective against Candida tropicalis, PQ11 is effective against Candida albicans) have potent antifungal activity. The results revealed that PQ9 showed similar antibacterial activity against Staphylococcus epidermidis compared clinically prevalent antibacterial drugs cefuroxime. PQ11 exhibited the highest antibacterial activity against S. epidermidis, which was about fourfold better than that of cefuroxime. Owing to their outstanding activities, PQ9 and PQ11 were chosen for a further investigation for biofilm and cytotoxicity evaluation. Based on the tests performed, there was a significant positive correlation between inhibition of the biofilm attachment and time. In addition, PQ9 and PQ11 showed cytotoxic effects at high concentrations on Balb/3T3, HaCaT, HUVEC, and NRK-52E cells (>24 and >18 µg/mL, respectively). Thus, two analogs (PQ9 and PQ11) were identified as the hits with the strong antibacterial efficiency against the S. epidermidis with low MIC values.


Subject(s)
Amines/chemical synthesis , Anti-Infective Agents/chemical synthesis , Benzoquinones/chemical synthesis , Benzoquinones/pharmacology , Plastoquinone/analogs & derivatives , Amines/chemistry , Amines/pharmacology , Animals , Anti-Infective Agents/chemistry , Anti-Infective Agents/pharmacology , BALB 3T3 Cells , Benzoquinones/chemistry , Biofilms/drug effects , Candida tropicalis/drug effects , Candida tropicalis/growth & development , Cell Line , Green Chemistry Technology , Human Umbilical Vein Endothelial Cells , Humans , Mice , Molecular Structure , Staphylococcus epidermidis/drug effects , Staphylococcus epidermidis/growth & development , Structure-Activity Relationship
20.
PLoS One ; 14(8): e0221033, 2019.
Article in English | MEDLINE | ID: mdl-31437188

ABSTRACT

Candidemia has been considered a persistent public health problem with great impact on hospital costs and high mortality. We aimed to evaluate the epidemiology and prognostic factors of candidemia in a tertiary hospital in Northeast Brazil from January 2011 to December 2016. Demographic and clinical data of patients were retrospectively obtained from medical records and antifungal susceptibility profiling was performed using the broth microdilution method. A total of 68 episodes of candidemia were evaluated. We found an average incidence of 2.23 episodes /1000 admissions and a 30-day mortality rate of 55.9%. The most prevalent species were Candida albicans (35.3%), Candida tropicalis (27.4%), Candida parapsilosis (21.6%) and Candida glabrata (11.8%). Higher mortality rates were observed in cases of candidemia due to C. albicans (61.1%) and C. glabrata (100%), especially when compared to C. parapsilosis (27.3%). Univariate analysis revealed some variables which significantly increased the probability of death: older age (P = 0.022; odds ratio [OR] = 1.041), severe sepsis (P < 0.001; OR = 8.571), septic shock (P = 0.035; OR = 3.792), hypotension (P = 0.003; OR = 9.120), neutrophilia (P = 0.046; OR = 3.080), thrombocytopenia (P = 0.002; OR = 6.800), mechanical ventilation (P = 0.009; OR = 8.167) and greater number of surgeries (P = 0.037; OR = 1.920). Multivariate analysis showed that older age (P = 0.040; OR = 1.055), severe sepsis (P = 0.009; OR = 9.872) and hypotension (P = 0.031; OR = 21.042) were independently associated with worse prognosis. There was no resistance to amphotericin B, micafungin or itraconazole and a low rate of resistance to fluconazole (5.1%). However, 20.5% of the Candida isolates were susceptible dose-dependent (SDD) to fluconazole and 7.7% to itraconazole. In conclusion, our results could assist in the adoption of strategies to stratify patients at higher risk for developing candidemia and worse prognosis, in addition to improve antifungal management.


Subject(s)
Candidemia/diagnosis , Candidemia/epidemiology , Cross Infection/diagnosis , Cross Infection/epidemiology , Shock, Septic/diagnosis , Shock, Septic/epidemiology , Adult , Age Factors , Aged , Analysis of Variance , Antifungal Agents/therapeutic use , Brazil/epidemiology , Candida albicans/drug effects , Candida albicans/growth & development , Candida albicans/pathogenicity , Candida glabrata/drug effects , Candida glabrata/growth & development , Candida glabrata/pathogenicity , Candida parapsilosis/drug effects , Candida parapsilosis/growth & development , Candida parapsilosis/pathogenicity , Candida tropicalis/drug effects , Candida tropicalis/growth & development , Candida tropicalis/pathogenicity , Candidemia/drug therapy , Candidemia/mortality , Cross Infection/drug therapy , Cross Infection/mortality , Drug Resistance, Fungal , Female , Humans , Hypertension/diagnosis , Hypertension/physiopathology , Incidence , Male , Middle Aged , Prognosis , Respiration, Artificial/adverse effects , Respiration, Artificial/statistics & numerical data , Retrospective Studies , Risk Factors , Shock, Septic/drug therapy , Shock, Septic/mortality , Survival Analysis , Tertiary Care Centers , Thrombocytopenia/diagnosis , Thrombocytopenia/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL
...